@user6963557781443: وإذا حكمتم بين الناس فأحكموا بالعدل

عيسى الوسيع
عيسى الوسيع
Open In TikTok:
Region: LY
Monday 14 September 2026 01:40:45 GMT
9836
372
3
65

Music

Download

Comments

amal14604
amal14 :
ونعم بالله
2026-10-14 19:57:46
0
p_o_i_q
abi_10s :
حسبي الله ونعم الوكيل
2026-09-14 19:32:10
0
zrm646
النـور :
( حتى إذا فرحوا بما اوتوا اخذناهم بغتة) ( وما ربك بظلام للعبيد ) حسبي آلله ونعم الوكيل اجعلها فى توا والحين يارب العالمين
2026-09-14 12:39:23
1
To see more videos from user @user6963557781443, please go to the Tikwm homepage.

Other Videos

Trading news you missed: Anthropic: Anthropic launched Claude Design yesterday, an Opus 4.7-powered tool that turns text prompts into prototypes. Design software stocks slid on the news, adding to a brutal ~26% decline in the S&P Software & Services Index this year as AI disruption fears mount. The real signal for investors: annualised revenue hit $30 billion by early April, up from just $9 billion at year-end 2025, with 1,000+ enterprise customers now spending $1M+ annually. VCs are dangling $800 billion+ valuations for a new round, more than double February's $380 billion, and Anthropic keeps saying no, Bloomberg which strongly suggests they're holding out for a public listing. Every product launch is pre-IPO momentum building, and the runway to that Nasdaq debut is getting shorter. Cerebras Systems (CBRS)  Cerebras Systems Inc. filed a public S-1 registration statement with the SEC on April 17 for an IPO on Nasdaq under the ticker
Trading news you missed: Anthropic: Anthropic launched Claude Design yesterday, an Opus 4.7-powered tool that turns text prompts into prototypes. Design software stocks slid on the news, adding to a brutal ~26% decline in the S&P Software & Services Index this year as AI disruption fears mount. The real signal for investors: annualised revenue hit $30 billion by early April, up from just $9 billion at year-end 2025, with 1,000+ enterprise customers now spending $1M+ annually. VCs are dangling $800 billion+ valuations for a new round, more than double February's $380 billion, and Anthropic keeps saying no, Bloomberg which strongly suggests they're holding out for a public listing. Every product launch is pre-IPO momentum building, and the runway to that Nasdaq debut is getting shorter. Cerebras Systems (CBRS) Cerebras Systems Inc. filed a public S-1 registration statement with the SEC on April 17 for an IPO on Nasdaq under the ticker "$CBRS" The AI chipmaker reported $510 million in revenue for 2025, representing a 76% increase from 2024, and achieved profitability with net income of $87.9 million after a $485 million net loss the prior year. Mena-fintech Key deals disclosed in the filing include OpenAI agreeing to deploy 750 megawatts of Cerebras's AI compute, with an option to buy an additional 1.25 gigawatts. In March, Cerebras also signed a deal with Amazon to enable cloud services on Cerebras chips. AcuraZine A May listing window is expected. Bitcoin + Crypto market Bitcoin $BTC spiked to a two-month high of roughly $77,400 on Friday, jumping 5% after Iranian Foreign Minister Seyed Abbas Araghchi announced the immediate reopening of the Strait of Hormuz to commercial vessels. Investing News Network Traditional markets mirrored the crypto surge, with the S&P 500 and Nasdaq hitting record highs while WTI crude plummeted 11%. Altcoins caught the tailwind too, Ethereum climbed to $2,440 and $Sol popped past $90. $ETH was up 3% over 24 hours, XRP up 2% at $1.49. On April 17, 2026, Kailera Therapeutics made a notable entrance on Nasdaq under the ticker symbol KLR, opening at $26 per share, a 62.5% increase from its initial public offering (IPO) price of $16. The stock maintained an impressive gain of approximately 57%, pushing the company's market capitalization beyond $2 billion. The IPO raised $625 million, marking it as the largest biotech IPO in the U.S. since 2021. Kailera Therapeutics $KLR Kailera had a standout Nasdaq debut on April 17, pricing its IPO at $16 and opening at $26, a jump of over 60% out of the gate. Shares held most of those gains through the session, pushing the company's market cap past $2 billion. The $625 million raise makes it the biggest US biotech IPO in five years, a strong signal that investor appetite for healthcare listings is back in a meaningful way.

About